A Holistic Approach to Study Non-Addictive Natural Products for Pain Management
National Institutes of Health
Classification and identifiers
- Solicitation number
- PAR-28-009
- Assistance listing (CFDA)
- 93.473
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
The National Center for Complementary and Integrative Health (NCCIH) intends to publish a Notice of Funding Opportunity (NOFO) to support collaborative interdisciplinary research that advances foundational understanding of non-addictive natural products for chronic pain management through a holistic, system-oriented approach. This initiative aligns with the NIH Helping to End Addiction Long-term (HEAL) Initiative by promoting safe, non-addictive, and prevention-oriented strategies for pain relief. Chronic pain affects tens of millions of adults in the United States, contributing to disability, diminished quality of life, and significant healthcare costs. Despite widespread public use of natural products, such as botanicals, dietary supplements, and other naturally derived compounds for pai...
Related opportunities
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2027Up to $350K
- Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0National Institutes of Health
- HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)National Institutes of HealthCloses in 10 daysUp to $100K
- NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)National Institutes of HealthCloses Nov 2026
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)National Institutes of HealthCloses Nov 2026Up to $1.1M
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)National Institutes of HealthCloses Nov 2026Up to $350K